These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10868297)

  • 1. Molecules that inhibit T-cell functions: cytochemical localization and shuttling.
    Santoro G; Anastasi G; Saverino D; Puri C; Zarcone D; Tacchetti C; Ciccone E; Grossi CE
    Eur J Histochem; 2000; 44(1):89-99. PubMed ID: 10868297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy of the immune system: facts and problems.
    Grossi CE; Ciccone E; Tacchetti C; Santoro G; Anastasi G
    Ital J Anat Embryol; 2000; 105(4):97-124. PubMed ID: 11265217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
    Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
    J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo.
    Rao S; Vasu C; Martinez O; Kaithamana S; Prabhakar BS; Holterman MJ
    Clin Immunol; 2001 Nov; 101(2):136-45. PubMed ID: 11683572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells.
    Paas-Rozner M; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6676-81. PubMed ID: 12743364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population.
    Anderson DE; Bieganowska KD; Bar-Or A; Oliveira EM; Carreno B; Collins M; Hafler DA
    Nat Med; 2000 Feb; 6(2):211-4. PubMed ID: 10655112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 negative signaling via lipid rafts: A new perspective.
    Rudd CE; Martin M; Schneider H
    Sci STKE; 2002 Apr; 2002(128):pe18. PubMed ID: 11972356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
    Walunas TL; Bluestone JA
    J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated T cells can induce high levels of CTLA-4 expression on B cells.
    Kuiper HM; Brouwer M; Linsley PS; van Lier RA
    J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.